These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 9507642

  • 1. Pneumocystis carinii and the immune response in disease.
    Hanano R, Kaufmann SH.
    Trends Microbiol; 1998 Feb; 6(2):71-5. PubMed ID: 9507642
    [Abstract] [Full Text] [Related]

  • 2. Lymphocytes in host defense against Pneumocystis carinii.
    Beck JM, Harmsen AG.
    Semin Respir Infect; 1998 Dec; 13(4):330-8. PubMed ID: 9872630
    [Abstract] [Full Text] [Related]

  • 3. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes.
    Beck JM, Warnock ML, Curtis JL, Sniezek MJ, Arraj-Peffer SM, Kaltreider HB, Shellito JE.
    Am J Respir Cell Mol Biol; 1991 Aug; 5(2):186-97. PubMed ID: 1679991
    [Abstract] [Full Text] [Related]

  • 4. [Pneumocystis pneumonia].
    Fujii T.
    Nihon Rinsho; 2008 Dec; 66(12):2367-72. PubMed ID: 19069107
    [Abstract] [Full Text] [Related]

  • 5. Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome.
    Thomas CF, Limper AH.
    Semin Respir Infect; 1998 Dec; 13(4):289-95. PubMed ID: 9872625
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pneumocystis carinii is still a dangerous opportunist. The infection is continuously a threat to immunocompromised patients].
    Olsson M, Elvin K, Linder E, Löfdahl S, Wahlgren M.
    Lakartidningen; 1999 Jan 27; 96(4):328-31. PubMed ID: 10024821
    [Abstract] [Full Text] [Related]

  • 12. Identification of antigens and antibodies specific for Pneumocystis carinii.
    Kovacs JA, Halpern JL, Swan JC, Moss J, Parrillo JE, Masur H.
    J Immunol; 1988 Mar 15; 140(6):2023-31. PubMed ID: 3257995
    [Abstract] [Full Text] [Related]

  • 13. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.
    Shellito JE, Kolls JK, Olariu R, Beck JM.
    J Infect Dis; 1996 Feb 15; 173(2):432-9. PubMed ID: 8568306
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Murine CD4+ T lymphocyte subsets and host defense against Pneumocystis carinii.
    Shellito JE, Tate C, Ruan S, Kolls J.
    J Infect Dis; 2000 Jun 15; 181(6):2011-7. PubMed ID: 10837183
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pentamidine aerosol to prevent Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1989 Oct 06; 31(802):91-2. PubMed ID: 2571064
    [No Abstract] [Full Text] [Related]

  • 20. The role of CD8+ T cells in the pathogenesis of Pneumocystis carinii pneumonia in mice depleted of CD4+ T cells.
    An CL, Su XP, Harmsen AG.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000 Oct 06; 18(4):207-12. PubMed ID: 12567660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.